Page last updated: 2024-09-04

ezetimibe and bms-262084

ezetimibe has been researched along with bms-262084 in 1 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(bms-262084)
Trials
(bms-262084)
Recent Studies (post-2010) (bms-262084)
2,4845631,4651203

Protein Interaction Comparison

ProteinTaxonomyezetimibe (IC50)bms-262084 (IC50)
Urokinase-type plasminogen activatorHomo sapiens (human)0.135
Cationic trypsinBos taurus (cattle)0.072
Coagulation factor XIHomo sapiens (human)0.0028
Trypsin-1Homo sapiens (human)0.0273
Trypsin-2Homo sapiens (human)0.05
Trypsin-3Homo sapiens (human)0.05
Plasminogen Rattus norvegicus (Norway rat)0.43
Tryptase alpha/beta-1Homo sapiens (human)0.0042
Tryptase deltaHomo sapiens (human)0.0042
Tryptase gammaHomo sapiens (human)0.0042

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mehta, PD; Pathak, AK; Sengar, NP1

Reviews

1 review(s) available for ezetimibe and bms-262084

ArticleYear
2-Azetidinone--a new profile of various pharmacological activities.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:12

    Topics: Animals; Anti-Infective Agents; Antifungal Agents; Antiparkinson Agents; Azetidines; Humans; Hypoglycemic Agents

2010